Tocilizumab‐induced cytomegalovirus colitis in a patient with COVID‐19

The authors urge clinicians to observe for early signs of CMV reactivation in patients presenting with gastrointestinal bleeding and intestinal perforation after receiving tocilizumab or other immunosuppressive therapy as a treatment for COVID 19. Early recognition of CMV infection and treatment wil...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Case Rep
Asıl Yazarlar: Khatib, Mohamad Y., Shaik, Karimulla S., Ahmed, Amna A., Alwraidat, Mohammad A., Mohamed, Ahmed S., Abou Kamar, Mohamad R., Sharaf Eldean, Mouhammad Z., Aldaraiseh, Bashar K., Nashwan, Abdulqadir J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2020
Konular:
Case Reports
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7813092/
https://ncbi.nlm.nih.gov/pubmed/33489151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.3487
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller